General information about company

Scrip code*500412
NSE Symbol*TIRUMALCHM
MSEI Symbol*NOTLISTED
ISIN*INE338A01024
Name of companyThirumalai Chemicals Limited
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Date of board meeting when results were approved14-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange10-02-2026
Description of presentation currencyINR
Level of roundingLakhs
Reporting TypeQuarterly
Reporting QuarterThird quarter
Nature of report standalone or consolidatedConsolidated
Whether results are audited or unaudited for the quarter endedUnaudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedUnaudited
Segment ReportingSingle segment
Description of single segmentChemical products and its intermediaries
Start date and time of board meeting14-02-2026 10:30
End date and time of board meeting14-02-2026 13:50
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualificationNot applicable



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-10-202501-04-2025
Date of end of reporting period31-12-202531-12-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations41585131127
Other income3971041
Total income41982132168
2Expenses
(a)Cost of materials consumed32650107678
(b)Purchases of stock-in-trade216303
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade954-3361
(d)Employee benefit expense 19626681
(e)Finance costs21496540
(f)Depreciation, depletion and amortisation expense22656708
(g)Other Expenses
1Other expenses731223959
Total other expenses731223959
Total expenses47508148508
3Total profit before exceptional items and tax-5526-16340
4Exceptional items 00
5Total profit before tax-5526-16340
6Tax expense
7Current tax2020
8Deferred tax-889-2369
9Total tax expenses-869-2349
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations-4657-13991
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method00
16Total profit (loss) for period-4657-13991
17Other comprehensive income net of taxes-1692901
18Total Comprehensive Income for the period-4826-11090
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent00
Total profit or loss, attributable to non-controlling interests00
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent00
Total comprehensive income for the period attributable to owners of parent non-controlling interests00
21Details of equity share capital
Paid-up equity share capital12061206
Face value of equity share capital11
22Reserves excluding revaluation reserve
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations-3.92-12.72
Diluted earnings (loss) per share from continuing operations-3.92-12.72
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations-3.92-12.72
Diluted earnings (loss) per share from continuing and discontinued operations-3.92-12.72
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Other Comprehensive Income

Date of start of reporting period01-10-202501-04-2025
Date of end of reporting period31-12-202531-12-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
1Re-measurements of defined benefit plans35.00-39.00
2Equity instruments through other comprehensive income, net-2097.00-2322.00
3Income tax relating to items that will not be reclassified to profit and loss296.00346.00
Total Amount of items that will not be reclassified to profit and loss-1766.00-2015.00
2Income tax relating to items that will not be reclassified to profit or loss 0.000.00
3Amount of items that will be reclassified to profit and loss
1Exchange differences on translation of foreign operations1607.005212.00
2Cash flow hedge reserve-10.00-296.00
Total Amount of items that will be reclassified to profit and loss1597.004916.00
4Income tax relating to items that will be reclassified to profit or loss 0.000.00
5Total Other comprehensive income-169.002901.00